Transcription of Botulinum Toxins A and B - UHCprovider.com
{{id}} {{{paragraph}}}
Example: bachelor of science
Botulinum Toxins A and B - UHCprovider.com
Botulinum Toxins A and B Page 1 of 24 UnitedHealthcare Commercial Medical Benefit Drug Policy Effective 04/01/2021 Proprietary Information of UnitedHealthcare. Copyright 2021 United HealthCare Services, Inc. UnitedHealthcare Commercial Medica l Benefit Drug Policy Botulinum Toxins A and B Policy Number: 2021D0017AB Effective Date: April 1, 2021 Instructions for Use Table of Contents Page Coverage Rationale .. 1 Applicable Codes .. 6 8 Benefit Considerations .. 8 Clinical Evidence .. 8 Food and Drug Administration .. 18 References .. 19 Policy History/Revision Information .. 23 Instructions for Use .. 23 Coverage Rationale See Benefit Considerations This policy refers to the following Botulinum toxin types A and B: Dysport (abobotulinumtoxinA) Xeomin (incobotulinumtoxinA) Botox (onabotulinumtoxinA) Myobloc (rimabotulinumtoxinB) The following information pertains to medical necessity review: General Requirements (applicable to all medical necessity requests) For initial therapy
o Stroke o Other injury, disease, or tumor of the brain or spinal cord . Unproven Dysport, Myobloc, and Xeomin are unproven and not medically necessary for the treatment of chronic migraine headache . 14,15,24,25-6,64,75,81. Botox, Dysport, Myobloc, and Xeomin are unproven and not medically necessary for the treatment of the following conditions :
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: